CONFERENCE VIDEOS COMING SOON
Thank you to everyone who came to the conference on July 12th and helped to make the event an outstanding success. We really hope you all enjoyed the conference, and we’d like to thank our on-site volunteers and staff for working tirelessly to make sure things went smoothly. Finally, we would like to thank our sponsors and speakers for their support. We hope to see you all again at our next conference!
We have recorded the talks and panels from the conference, and we will be making them available on our website in the next few weeks once we have edited them. As a special thank you, the Lifespan Heroes, our monthly patrons, will be offered early access to these videos before their public release. More information will be announced soon.
BRINGING REJUVENATION BIOTECHNOLOGY AND INVESTORS TOGETHER
At the Frederick P. Rose Auditorium, Cooper Union in New York City, we will be hosting a special one-day conference focused on aging research and biotech investment. Developing therapies from initial concepts, through clinical testing, and ultimately to market takes a pipeline, and right now, that pipeline is being built to support the next step in medicine: rejuvenation biotechnology. Join us for this exciting event, where industry experts will be sharing their insights on the advances and investment prospects in an industry poised to revolutionize medicine forever.
OFFICIAL EVENT SPONSORS
INDUSTRY EXPERTS FROM RESEARCH AND INVESTMENT
We bring you insights from the leading experts in research and biotech investment, who will guide you through the industry in a series of talks and presentations. Below are the confirmed guests, and we will be announcing more speakers soon, so be sure to check back with us often to see who else will be joining us.
We have a feature-packed event program planned for you to enjoy, and it will include an overview of progress in the field, prospects for translational research, venture philanthropy, policy and regulation insights, and the challenges that the industry faces.